LG
ABBV icon

Leuthold Group’s AbbVie ABBV Stock Holding History

Leuthold Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-49,973
Closed -$7.96M – 200
2023
Q1 		$7.96M Sell
49,973
-1,021
-2% -$156K 1.05% 22
2022
Q4 		$8.24M Sell
50,994
-1,661
-3% -$255K 1.11% 20
2022
Q3 		$7.07M Buy
+52,655
New +$7.56M 1.06% 23
2021
Q2 		– Sell
-45,677
Closed -$4.94M – 183
2021
Q1 		$4.94M Sell
45,677
-4,139
-8% -$443K 0.62% 60
2020
Q4 		$5.34M Sell
49,816
-2,240
-4% -$215K 0.7% 48
2020
Q3 		$4.56M Sell
52,056
-1,029
-2% -$96.9K 0.63% 56
2020
Q2 		$5.21M Sell
53,085
-1,344
-2% -$118K 0.78% 45
2020
Q1 		$4.15M Sell
54,429
-4,923
-8% -$419K 0.75% 43
2019
Q4 		$5.25M Buy
+59,352
New +$4.93M 0.68% 61
2019
Q3 		– Sell
-53,674
Closed -$3.9M – 174
2019
Q2 		$3.9M Sell
53,674
-3,415
-6% -$268K 0.5% 83
2019
Q1 		$4.6M Buy
57,089
+22,097
+63% +$1.81M 0.62% 67
2018
Q4 		$3.23M Sell
34,992
-2,449
-7% -$215K 0.46% 83
2018
Q3 		$3.54M Buy
+37,441
New +$3.55M 0.39% 102
2018
Q1 		– Sell
-108,567
Closed -$10.5M – 192
2017
Q4 		$10.5M Buy
108,567
+17,389
+19% +$1.64M 1.05% 18
2017
Q3 		$8.1M Sell
91,178
-1,134
-1% -$86.3K 0.82% 31
2017
Q2 		$6.69M Sell
92,312
-3,216
-3% -$216K 0.72% 41
2017
Q1 		$6.22M Sell
95,528
-2,126
-2% -$134K 0.67% 47
2016
Q4 		$6.12M Sell
97,654
-7,623
-7% -$465K 0.68% 42
2016
Q3 		$6.64M Buy
+105,277
New +$6.82M 0.7% 49

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Leuthold Group's ABBV Position: Q2 2023 in Review

Leuthold Group sold out of AbbVie (ABBV) in Q2 2023, closing a stake of 49,973 shares — an estimated $7.96M sold.

Leuthold Group first reported a position in ABBV in Q3 2016 and held it in 19 quarters. The position peaked at $10.5M in Q4 2017. 3,077 funds tracked by Wall St. Rank hold ABBV as of Q2 2023.

  • Leuthold Group reported no remaining AbbVie position as of Q2 2023 after selling out during the quarter.
  • Leuthold Group sold 49,973 AbbVie shares in Q2 2023, an estimated $7.96M.
  • Leuthold Group first reported a position in AbbVie in Q3 2016 and held it in 19 quarters.
  • Leuthold Group's AbbVie position peaked at $10.5M in Q4 2017.
  • 3,077 funds tracked by Wall St. Rank held AbbVie as of Q2 2023.

Based on Leuthold Group's 13F filing for Q2 2023, filed 8 Aug 2023.